Projected Sales Volume: windtreetx.com (WINT)

Corporate emblem and logo of Windtree Therapeutics (WINT)

Windtree Therapeutics (WINT) relies on external partners for primary testing while maintaining molecule synthesis in-house. The firm's projected sales level illustrates the link between market value and expectations, where the value 0.00 captures this metric. Business stability is based on the development of heart failure treatments, and a closed patent perimeter for peptide therapies firmly ties clinics to the company's protocols.

Windtree Therapeutics, Inc. - WINT Company Future Revenue (period 07/04/2022 - 09/06/2025)

Financial and market metric breakdowns for Windtree (WINT)

- stock quotes and analyst forecast:
Stock Price Windtree Therapeutics|WINT - Average Forecast Price
- company stock exchange capitalization indicators:
Market Capitalization Windtree Therapeutics Inc.|WINT - Total Enterprise Value
- book capitalization information:
Accounting Value per Share Windtree Therapeutics|WINT - Accounting Value of Company|Market Cap to Net Assets Ratio windtreetx.com|WINT - Aggregate Business Assets
- debt level and financial liquidity data:
Total Debt to Capital Windtree Therapeutics|WINT - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Windtree Therapeutics|WINT - Company Cumulative Debt|Debt to Book Capitalization Ratio Windtree Therapeutics Inc.|WINT - Company Long-Term Loans and Borrowings|Company Short-Term Debts Windtree Therapeutics|Quick Liquidity windtreetx.com
- financial results and valuation multiples details:
WINT - Profit After Tax|Projected Future Earnings Windtree Therapeutics|WINT - Market Cap to Earnings|Projected Price to Earnings Windtree Therapeutics|WINT - PEG Multiple|Enterprise Value to EBITDA Ratio Windtree Therapeutics Inc.|WINT - Company profit before taxes, interest and amortization|Net earnings per share (EPS TTM) Windtree Therapeutics|WINT - Net earnings per share for the last four quarters|Quarterly EPS earnings growth windtreetx.com|WINT - Net earnings per share growth this year|Net earnings per share growth forecast for next year Windtree Therapeutics
- sales volume and revenue information:
WINT - Company Gross Revenue|Company Future Sales Volume Windtree Therapeutics|WINT - Market Cap to Revenue|Forward P/S Multiple Windtree Therapeutics Inc.
Analysis of all company metrics:WINT Windtree Therapeutics, Inc.
Brand item of Windtree

Windtree Therapeutics (WINT) provides critical drug logistics for emergency cardiology. This indicator aggregates daily commercial transaction dynamics, reflecting real demand for products. Analysis of current revenue streams allows for an objective assessment of business stability, excluding macroeconomic distortions. For the investor, this serves as a risk management tool against capital freeze. The trajectory of future sales volumes clearly demonstrates the efficiency of clinic supply chains.

Direct competitors

Projected Sales Volume REGN|IRTC - Company Expected Sales Volume|Projected Sales Volume LNTH (Lantheus)|Mineralys (MLYS) - Company Expected Sales Volume|HTFL: Company Future Sales Volume|Company Future Revenue KMTS (Kestra Medical Corp)|ESPR (Esperion Therapeutics) - Company Future Sales Volume|AMRN: Company Projected Revenue Volume|AVR (Anteris) - Projected Sales Volume|TNYA: Company Future Revenue|Projected Sales Volume CVRX|MIST - Company Expected Sales Volume|Company Projected Revenue Cardiol Therapeutics Inc. CRDL|Company Future Revenue BEAT|Tenax Therapeutics, Inc. - Projected Sales Volume|ADGM - Projected Sales Volume|BioCardia, Inc (BCDA) - Company Projected Revenue|Company Expected Revenue VTAK (Catheter Precision Corporation)|ABIO (ARCA Biopharma Inc) - Projected Sales Volume|Company Expected Sales Volume Acasti ACST|Company Future Sales Volume AVTE (Aerovate Therapeutics, Inc.)|Projected Sales Volume vervetx.com (VERV)